Province provides relief for Ontarians using the Ontario Drug Benefit Program
May 13, 2020 4:02 P.M. Ministry of Health
TORONTO — The Ontario Government is making the cost of prescription drugs more affordable. Effective today, people using the Ontario Drug Benefit Program will not be required to pay any co-payment until July 1, 2020 for any prescription of 30+ days that is now being dispensed in installments. In addition, existing and new Trillium Drug Program households can apply for an income reassessment to help reduce the financial burden for families during the outbreak.
"During these unprecedented times, our government is doing everything we can to provide additional relief for vulnerable people impacted by COVID-19," said Christine Elliott, Deputy Premier and Minister of Health. "That's why we are taking action to help ensure Ontarians continue to have access to the prescription drugs they need, without it being a source of stress or financial burden during the outbreak."
If a Trillium Drug Program household has experienced an income change in 2019 or 2020 of 10 per cent or more compared to their 2018 income, they can apply to have their deductible recalculated by completing and submitting the Annual Deductible Re-Assessment Form. Eligible households who are not currently enrolled in the Trillium Drug Program and have high prescription costs can also complete and submit an application and re-assessment form by e-mail or fax.
Quick Facts
- To ensure there is an adequate supply of medications in the province during COVID-19, pharmacists and physicians are dispensing 30-days or less of medication at a time, with some exceptions.
- Ontarians should call their pharmacy within 10 days before the end of their prescription for a refill and ask about delivery options if they can’t pick up the medicine themselves.
Additional Resources
- Get help with high prescription drug costs
- Ontario’s Action Plan: Responding to COVID-19
- Visit Ontario's website to learn more about how the province continues to protect Ontarians from COVID-19.